Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vitro
Type of information:
experimental study
Adequacy of study:
key study
Study period:
09 November 2018 to 16 November 2018
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2019
Report date:
2019

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 442D (In Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of study:
activation of keratinocytes
Justification for non-LLNA method:
The KeratinoSens™ test is a method for which validation studies have been completed followed by an independent peer review conducted by the European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM). The KeratinoSens™ test method was considered scientifically valid to be used as part of an IATA (Integrated Approach to Testing and Assessment), to support the discrimination between skin sensitisers and non-sensitisers for the purpose of hazard classification and labelling.

Test material

Constituent 1
Chemical structure
Reference substance name:
2-ethoxyethyl ethyl carbonic acid ester
EC Number:
809-934-0
Cas Number:
627034-93-9
Molecular formula:
C7H14O4
IUPAC Name:
2-ethoxyethyl ethyl carbonic acid ester
Test material form:
liquid
Details on test material:
- Appearance: clear, colourless liquid
- Storage conditions: room temperature, in the dark

In vitro test system

Details on the study design:
CONTROLS
- Negative Control: DMSO
- Positive Control: Cinnamic Aldehyde

TEST SYSTEM
- The KeratinoSens™ cell line (test system) is an immortalised adherent cell line derived from HaCaT human keratinocytes, stably transfected with a selectable plasmid containing the luciferase gene under the transcriptional control of the Anti-oxidant Response Element (ARE) from a gene that is known to be up-regulated by contact sensitisers. The luciferase signal reflects the activation by sensitisers of endogenous Nrf2 dependent genes, and the dependence of the luciferase signal in the recombinant cell line on Nrf2 has been demonstrated. This allows quantitative measurement (by luminescence detection) of luciferase gene induction, using well established light producing luciferase substrates, as an indicator of the activity of the Nrf2 transcription factor in cells following exposure to electrophilic test substances.
- Method of administration of test material: Per plate, a single application of 12 concentrations of the test material was applied in cell culture medium (dilution factor of 2) with a final concentration of DMSO of 1%. The top concentration was previously determined by solubility testing.
- Method of administration of reference materials: Per plate, a single application of 5 concentrations of the positive control was applied in cell culture medium (dilution factor of 2) with a final concentration of DMSO of 1% and a single application of culture medium with 1% DMSO was applied as the negative control (6 wells per plate). One well per plate was left empty (no cells).
- Exposure times of test materials and reference materials: Cells were incubated with the test or reference material for 48 ± 2h prior to endpoint measurements.
- Number of repetitions: Three repetitions (runs) were performed. Each repetition consisted of 3 x 96-well plates for luminescence (n=9 overall) and 2 x 96-well plates for MTT (n=6 overall). The validity of each repetition was assessed following acceptance criteria.

OVERVIEW
- Preliminary testing: Determination of the top concentration by solubility testing
- Day 1: Cell seeding (3 x 96-well plates for Luminescence; 2 x 96-well plate for MTT); 10,000 cells per well, passage number 17.
- Day 2: 24 hours after seeding, the test and control materials were applied and plates were incubated at 37 °C, 5 % CO2, ≥ 95 % relative humidity for 48 ± 2 hours.
- Day 4: Evaluation of luciferase activity by luminescence (3 plates) and cell viability by MTT testing (2 plates)

DATA ANALYSIS
- XCellR8 Form F0056: “KeratinoSens data processing” v.2 was used to analyse data. This form is a Microsoft Excel workbook, validated in-house (24JUL18) containing formulae to process the raw data as described in SOP L0057.
- The following parameters were calculated using the KeratinoSens™ test method:
• The maximal average fold induction of luciferase activity (IMAX) value observed at any concentration of the test material and positive control.
• The EC1.5 value representing the concentration at which the induction of luciferase activity was above the 1.5-fold threshold (i.e. 50% enhanced luciferase activity).
• For each concentration showing > 1.5-fold luciferase activity induction, statistical significance is calculated (e.g. by a two-tailed Student’s t-test), comparing the luminescence values for the three replicate samples with the luminescence values in the solvent (negative) control wells to determine whether the luciferase activity induction is statistically significant (p < 0.05). The lowest concentration with > 1.5-fold luciferase activity induction is the value determining the EC1.5 value. It is checked in each case whether this value is below the IC30 value, indicating that there is less than 30% reduction in cellular viability at the EC1.5 determining concentration.
• The percentage of viability as compared to the Negative control.

ACCEPTANCE OF THE ASSAY
Test results are acceptable if:
• The positive control (cinnamic aldehyde) produces positive results, i.e. the luciferase gene induction produced by this control is above the threshold of 1.5 in at least one of the tested concentrations and this induction is statistically significant compared to the solvent (negative) control (p < 0.05).
• The lMAX and the EC1.5 for cinnamic aldehyde is calculated and meet either or both of the following targets: Average induction in the three replicates for cinnamic aldehyde at 32 µM is within the XCellR8 historical range (currently 1.6 and 3) or EC1.5 value for cinnamic aldehyde is within the XCellR8 historical range (currently 6 µM and 39 µM). At least one of these criteria must be met, otherwise the run is discarded unless there is sufficient reason not to do this as determined by the Study Director. If only one criterion is met, it is recommended to check the dose-response curve of cinnamic aldehyde in order to decide on acceptability.
• CV % of blank values < 20 %

INTERPRETATION OF RESULTS
A test material is considered positive using the KeratinoSens prediction model if the following conditions are met in 2 of 3 repetitions:
• The IMAX is higher than 1.5 fold and statistically significantly different as compared to the solvent (negative) control (as determined by a two-tailed, unpaired Student’s T-test).
• The cellular viability is higher than 70% at the lowest concentration with induction of luciferase activity above 1.5 fold (i.e. at the EC1.5 determining concentration). Test materials that only induce the gene activity at cytotoxic levels are not rated positive, as in the case for some non-sensitising skin irritants.
• The EC1.5 value is < 1000 µM or < 200 µg/mL for test materials with no defined MW.
• There is an apparent overall dose-response for luciferase induction (or a biphasic response).

Results and discussion

Positive control results:
The acceptance criteria stated that the Positive Control (PC) (Cinnamic aldehyde) must have induction >1.5-fold in at least one concentration, it showed this at 4/5 concentrations and therefore met the acceptance criteria.

In vitro / in chemico

Resultsopen allclose all
Key result
Group:
test chemical
Run / experiment:
run/experiment 1
Parameter:
Imax [442D]
Value:
1.226
At concentration:
500 mM
Cell viability:
103.327 %
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
other: The maximal average fold induction of luciferase activity (IMAX) value observed at any concentration.
Key result
Group:
test chemical
Run / experiment:
run/experiment 2
Parameter:
Imax [442D]
Value:
0.854
At concentration:
1 000 mM
Cell viability:
94.869 %
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
other: The maximal average fold induction of luciferase activity (IMAX) value observed at any concentration.
Key result
Group:
test chemical
Run / experiment:
run/experiment 3
Parameter:
Imax [442D]
Value:
1.443
At concentration:
1 000 mM
Cell viability:
108.383 %
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
other: The maximal average fold induction of luciferase activity (IMAX) value observed at any concentration.
Key result
Group:
test chemical
Run / experiment:
mean
Parameter:
EC 1.5 [442D]
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
other: N/A - threshold of induction not crossed at any test material concentration in any repetition.
Other effects / acceptance of results:
SOLUBILITY ASSESSMENT
- The test concentrations of the test material used in the KeratinoSens™ method were selected on the basis of a solubility test carried out during the study: Solubility of the test material was confirmed up to 200 mM in DMSO. Subsequent dilution in cell culture medium gave a top concentration of 2000 µM.

SKIN SENSITISATION
- In this study, the test material was classified as a Negative using the KeratinoSens prediction model.
- The sensitisation potential of the test material was quantified by calculating 2 parameters known as the EC1.5 and the IMAX value:
• The EC1.5 value is the Effective Concentration (EC) of test material that yielded an induction of luciferase activity greater than 1.5-fold over untreated controls. If at least one concentration induces statistically significant luciferase activity > 1.5, then the product is classified as positive provided the cell viability measured by MTT is greater than 70%. The test material did not induce statistically significant luciferase induction > 1.5 in any of the 3 repetitions. The statistical significance, viability, dose response and dose acceptance criteria were all met and therefore: The test material was classified as negative using the KeratinoSens prediction model.
• The IMAX value is the maximum induction observed within the concentration range tested. Although the KeratinoSens™ test is not validated to predict potency, the IMAX value can provide a useful tool for preliminary comparison of sensitisation potential between test materials. The maximum induction for rep 1 was 1.226 at 500.000 µM, 0.854 for rep 2 at 1000.000 µM and for rep 3 the maximum induction was 1.443 at 1000.000 µM. For reference, during test validation, sensitising proficiency chemicals produced IMAX values of up to 36-fold over untreated controls.
- All of the formal acceptance criteria of the tests were met.

Any other information on results incl. tables

Table 1: Results of Repetition 1

 

Test Material Concentration (µM)

0.977

1.953

3.906

7.813

15.625

31.250

62.500

125.000

250.000

500.000

1000.000

2000.000

Mean fold induction

0.716

1.043

1.043

1.094

1.128

1.061

1.187

1.165

1.158

1.226

1.059

0.818

Viability %

104.281

85.624

89.579

93.600

88.757

86.403

98.080

93.171

102.439

103.327

102.210

107.861

T-test

3.48E-03

6.54E-01

6.37E-01

3.24E-01

1.78E-01

5.18E-01

4.94E-02

7.79E-02

9.33E-02

1.67E-02

5.25E-01

5.80E-02

SD

0.122

0.209

0.054

0.166

0.155

0.145

0.124

0.073

0.111

0.043

0.024

0.160

IMAX

1.226 at 500.000 µM

EC1.5

N/A - threshold of induction not crossed at any test material concentration

IC30

N/A- Cell viability did not fall below 70%

IC50

N/A- Cell viability did not fall below 50%

 

Table 2: Results of Repetition 2

 

Test Material Concentration (µM)

0.977

1.953

3.906

7.813

15.625

31.250

62.500

125.000

250.000

500.000

1000.000

2000.000

Mean fold induction

0.519

0.689

0.667

0.699

0.673

0.731

0.804

0.752

0.770

0.831

0.854

0.526

Viability %

88.937

72.463

86.221

97.222

96.247

101.615

109.586

92.829

105.862

90.815

94.869

93.426

T-test

2.59E-06

1.73E-03

6.08E-04

2.09E-03

8.45E-04

5.86E-03

3.81E-02

9.41E-03

1.53E-02

7.48E-02

1.19E-01

3.51E-06

SD

0.060

0.170

0.046

0.128

0.107

0.148

0.101

0.076

0.062

0.118

0.089

0.065

IMAX

0.854 at 1000.000 µM

EC1.5

N/A - threshold of induction not crossed at any test material concentration

IC30

N/A- Cell viability did not fall below 70%

IC50

N/A- Cell viability did not fall below 50%

 

Table 3: Results of Repetition 3

 

Test Material Concentration (µM)

0.977

1.953

3.906

7.813

15.625

31.250

62.500

125.000

250.000

500.000

1000.000

2000.000

Mean fold induction

0.793

0.825

0.853

1.006

0.958

0.975

1.031

1.099

1.122

1.203

1.443

1.271

Viability %

141.968

97.441

105.926

96.755

102.259

102.534

98.897

94.869

107.917

109.373

108.383

136.691

T-test

2.87E-02

6.22E-02

1.16E-01

9.53E-01

6.52E-01

7.87E-01

7.39E-01

2.96E-01

1.93E-01

3.25E-02

1.38E-05

4.65E-03

SD

0.086

0.069

0.062

0.133

0.037

0.006

0.061

0.160

0.087

0.111

0.113

0.069

IMAX

1.443 at 1000.000 µM

EC1.5

N/A - threshold of induction not crossed at any test material concentration

IC30

N/A- Cell viability did not fall below 70%

IC50

N/A- Cell viability did not fall below 50%

 

Applicant's summary and conclusion

Interpretation of results:
other: Negative according to the KeratinoSens prediction model.
Conclusions:
Under the conditions of this study, the test material is negative according to the KeratinoSens prediction model.
Executive summary:

The skin sensitisation potential of the test material was investigated in accordance with the standardised guideline OECD 442D, under GLP conditions.

The human skin sensitisation potential of the test material was assessed using the validated in vitro method, the KeratinoSens™ assay, adapted to animal product-free conditions by the Test Facility, and validated in-house to determine keratinocyte activation.

After 48h exposure of cells with 12 concentrations of the test material, Luciferase measurements and MTT viability testing were performed.

The EC1.5 value is the Effective Concentration (EC) of test material that yielded an induction of luciferase activity greater than 1.5-fold over untreated controls. If at least one concentration induces statistically significant luciferase activity >1.5, then the product is classified as positive provided the cell viability measured by MTT is greater than 70%. The test material did not induce statistically significant luciferase induction >1.5 in any of the 3 repetitions. The statistical significance, viability, dose response and dose acceptance criteria were all met and therefore: The test material was classified as negative using the KeratinoSens prediction model.

The IMAX value is the maximum induction observed within the concentration range tested. Although the KeratinoSens™ test is not validated to predict potency, the IMAX value can provide a useful tool for preliminary comparison of sensitisation potential between test materials. The maximum induction for rep 1 was 1.226 at 500.000 µM, 0.854 for rep 2 at 1000.000 µM and for rep 3 the maximum induction was 1.443 at 1000.000 µM. For reference, during test validation, sensitising proficiency chemicals produced IMAX values of up to 36-fold over untreated controls. All of the formal acceptance criteria of the tests were met.

Under the conditions of this study, the test material is negative according to the KeratinoSens prediction model.